Orchestra BioMed Holdings Inc. (OBIO) financials · rev $33.5M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Orchestra BioMed Holdings Inc. (OBIO) rev $33.5M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $33.5M | $2.64M |
| Cost of Revenue | $190.0K | $204.0K |
| Gross Profit | $33.3M | $2.43M |
| Operating Income | -$51.8M | -$64.3M |
| Net Income | -$52.7M | -$61.0M |
| EPS (Diluted) | -$1.11 | -$1.66 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $114.9M | $76.2M |
| Current Assets | $107.9M | $69.2M |
| Cash & Equivalents | $34.7M | $22.3M |
| Inventory | $310.0K | $173.0K |
| PP&E | $1.72M | $1.38M |
| Total Liabilities | $51.5M | $43.2M |
| Current Liabilities | $16.7M | $16.2M |
| Long-term Debt | $15.0M | $15.0M |
| Total Debt | $15.0M† | $15.0M† |
| Shareholders' Equity | $53.6M | $33.0M |
| Retained Earnings | -$362.6M | -$309.9M |
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$49.0M | -$50.6M |
| CapEx | $489.0K | $289.0K |
| Investing Cash Flow | -$26.9M | $13.1M |
| Financing Cash Flow | $88.3M | $29.2M |
| Net Change in Cash | $12.4M | -$8.30M |
| Free Cash Flow | -$49.5M | -$50.8M |
FAQ
What is OBIO P/E and revenue?
Orchestra BioMed Holdings Inc. (OBIO) rev $33.5M.
What is OBIO revenue?
Orchestra BioMed Holdings Inc. last cached revenue is $33.5M (FY2025).
Is OBIO profitable?
Orchestra BioMed Holdings Inc. last cached net income is -$52.7M (FY2025).
What are OBIO total assets?
Orchestra BioMed Holdings Inc. last cached total assets are $114.9M (FY2025).
What is OBIO free cash flow?
Orchestra BioMed Holdings Inc. last cached free cash flow is -$49.5M (FY2025).
Not investment advice. Cached statements, not a live tape.